Endometrial Cancer — Proceedings from the 2026 Annual ONS Congress

Featuring perspectives from Dr Dana M Chase, Ms Sarah Karpen, Dr J Alejandro Rauh-Hain and Ms Jaclyn Shaver, moderated by Dr Chase, including the following topics: • Introduction: Biology of Endometrial Cancer (EC) (0:00) • First-Line Therapy for Advanced or Recurrent EC (14:15) • Potential Benefits of PARP Inhibition Combined with Immunotherapy in Advanced EC (35:13) • Role of Lenvatinib/Pembrolizumab in the Management of Progressive Advanced EC (57:48) • Other Nursing Considerations in the Care of Patients with Advanced EC (1:17:28) NCPD information and select publications (https://researchtopractice.com/ONS202...)